| Early Mineralocorticoid Receptor Antagonist Therapy for Low-Renin Essential Hypertension | Doxazosin | Phase 4 | Not yet recruiting | China National Center for Cardiovascular Diseases | Nov 12, 2026 |
| OB VEGA-Phenylephrine vs Norepinephrine Outcomes | Phenylephrine | Phase 4 | Not yet recruiting | Wake Forest University Health Sciences | Oct 28, 2026 |
| ED90 of Norepinephrine and Phenylephrine Infusion in Patients of Advanced Maternal Age | Phenylephrine | Not applicable | Not yet recruiting | General Hospital of Ningxia Medical University | Oct 26, 2026 |
| EMG-Guided Versus Endoscopic-Catheter Botulinum Toxin Injection for Spasmodic Dysphonia | Phenylephrine | Not applicable | Not yet recruiting | Chinese University of Hong Kong | Oct 26, 2026 |
| The Effect of Acupuncture on Passing Ureteral Stones | Tamsulosin | Not applicable | Recruiting | Hitit University | Oct 26, 2026 |
| "Anticipant"-TIPS After a First Portal-hypertension-related Complication in Cirrhosis | Carvedilol | Not applicable | Not yet recruiting | University Hospital, Toulouse | Oct 22, 2026 |
| Efficacy and Safety of Combination Therapy Compared With Monotherapy in Patients With Benign Prostatic Hyperplasia | Tamsulosin | Phase 3 | Not yet recruiting | Il-Yang Pharm. Co., Ltd. | Oct 13, 2026 |
| Assessing Trauma-related Links Between Affective and Metabolic Systems | Prazosin | Phase 4 | Not yet recruiting | VA Office of Research and Development | Oct 7, 2026 |
| Ceasing Alpha-blockers Early After Resection of the Prostate (The CLEAR Trial) | Tamsulosin | Phase 4 | Not yet recruiting | Shanghai East Hospital | Sep 29, 2026 |
| ED50/ED90 of Phenylephrine Infusion for Preventing Spinal Anesthesia-Induced Hypotension: Supine vs Left-Tilt 15° | Phenylephrine | Phase 4 | Not yet recruiting | Peking University People's Hospital | Sep 17, 2026 |
| Standard Versus Double Alpha Blockers Treatment for Symptomatic Benign Prostatic Obstruction | Tamsulosin | Phase 4 | Active, not recruiting | Mansoura University | Sep 11, 2026 |
| Superiority of Phenylephrine Versus Norepinephrine in Complex Spine Surgery (SPiNeS) | Phenylephrine | Phase 4 | Recruiting | Mayo Clinic | Sep 1, 2026 |
| Prospective Post Market Clinical Trial for the Zenflow Spring System - A Minimally Invasive Treatment for LUTS Associated With BPH. | Tamsulosin | Phase 4 | Not yet recruiting | Zenflow, Inc. | Sep 1, 2026 |
| Terazosin And Metabolic Engagement in Alzheimer's Disease | Terazosin | Phase 2 | Not yet recruiting | Qiang Zhang | Sep 1, 2026 |
| Iris Structural Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia Patients | Tamsulosin | Phase 4 | Not yet recruiting | Mohsen Pourazizi | Aug 3, 2026 |
| Pupil Size and Choroidal Thickness Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia Patients | Tamsulosin | Phase 4 | Not yet recruiting | Mohsen Pourazizi | Aug 3, 2026 |
| Robotic Systems Evaluation for Peripheral Pulmonary Lesions (RISE Trial) | Phenylephrine | Not applicable | Recruiting | Case Comprehensive Cancer Center | Jul 30, 2026 |
| Effects Of Scapulothoracic Intervention With Or Without Neural Mobilization In Patients With Cervico-Brachialgia | Phenylephrine | Not applicable | Not yet recruiting | Riphah International University | Jul 24, 2026 |
| Tamsulosin Monotherapy Versus Combination Therapy With Tadalafil (2.5 mg vs 5 mg) in Managing Male LUTS Secondary to BPH | Tamsulosin | Not applicable | Recruiting | Ain Shams University | Jul 23, 2026 |
| Daily Knee Sleeve Use Versus No Use in Older Adults With Chronic Knee Pain | Phenylephrine | Not applicable | Recruiting | Margaret L Gourlay, MD, MPH | Jun 30, 2026 |
| Underdilated VCX-TIPS Versus EVL Plus NSBB for Secondary Prophylaxis of Variceal Bleeding in Cirrhosis | Carvedilol | Not applicable | Not yet recruiting | West China Hospital | May 14, 2026 |
| Comparison of the Incidence of Major Cardiovascular Events Between the Combination of Percutaneous Intervention and Optimal Drug Therapy and the Optimal Drug Therapy Alone in Patients With Chronic Coronary Syndrome | Carvedilol | Not applicable | Not yet recruiting | Seoul National University Hospital | May 11, 2026 |
| Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis | Carvedilol | Phase 4 | Recruiting | Asian Institute Of Medical Sciences | Apr 9, 2026 |
| The Assessment of Partial Guideline-Directed Medical Therapy Down Titration in Heart Failure in Remission. | Carvedilol | Phase 4 | Recruiting | Ziekenhuis Oost-Limburg | Apr 7, 2026 |
| The Effect of Continuous Positive Airway Therapy on the Blood Pressure in Sleepy vs Non-sleepy Patients With Obstructive Sleep Apnea | Bunazosin | — | Active, not recruiting | King's College London | Mar 27, 2026 |
| Carvedilol and Midodrine Versus Carvedilol Alone in Preventing Early Rebleed in Patients With Cirrhosis. | Midodrine, Carvedilol | Not applicable | Not yet recruiting | Institute of Liver and Biliary Sciences, India | Mar 12, 2026 |
| Efficacy and Safety of Early Initiation of Midodrine for Control and Prevention of Ascites and Its Related Complications in Acute-on-chronic Liver Failure. | Midodrine | Not applicable | Not yet recruiting | Institute of Liver and Biliary Sciences, India | Feb 20, 2026 |
| Comparison of the Efficacy of Continuous Metaraminol Infusion Versus Continuous Norepinephrine Infusion for the Prevention of Hypotension During Cesarean Section Under Spinal Anaesthesia. A Randomised Controlled Trial. | Metaraminol | Not applicable | Not yet recruiting | Aretaieion University Hospital | Jan 23, 2026 |
| Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of Cirrhotic Varices | Carvedilol | Phase 4 | Enrolling by invitation | Xijing Hospital | Jan 20, 2026 |
| TACE Combined With Tislelizumab, Lenvatinib, and Carvedilol for Unresectable HCC With Cirrhotic Portal Hypertension | Carvedilol | Phase 2 | Not yet recruiting | Tongji Hospital | Jan 20, 2026 |
| Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial | Trimipramine | Phase 2 | Recruiting | Centre Hospitalier Universitaire Vaudois | Dec 4, 2025 |
| Effect of Terazosin on ATP Levels in People With Amyotrophic Lateral Sclerosis | Terazosin | Early phase 1 | Recruiting | University of Iowa | Nov 4, 2025 |
| Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm Multi-stage Platform Trial | Terazosin | Phase 3 | Recruiting | University College, London | Oct 3, 2025 |
| Comparison of Alpha Blockers (Terazosin and Tamsulosin) in Reducing Ureteral Stent Related Symptoms | Terazosin | Phase 3 | Recruiting | Penang Hospital, Malaysia | May 13, 2025 |
| Reduction of Edema With a Specialized Cocktail for Ultra-early Management in Ischemic Stroke | Terazosin | Phase 3 | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | Mar 7, 2025 |
| Reduction of Edema With a Specialized Cocktail for Ultra-early Management in Intracerebral Hemorrhage | Terazosin | Phase 3 | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | Mar 7, 2025 |
| Management of Non-Organic Dysphonia in Adults. | Bunazosin | Not applicable | Recruiting | Sohag University | Mar 4, 2025 |
| Brain Blood Vessel Responses to Changes in Blood Flow | Prazosin | Phase 2 | Recruiting | University of Wisconsin, Madison | Oct 8, 2024 |
| Brain Blood Vessel Responses to Changes in Blood Flow: Younger Cohort | Prazosin | Phase 2 | Recruiting | University of Wisconsin, Madison | Oct 8, 2024 |
| Midodrine in Heart Failure With Reduced Ejection Fraction With Hypotension | Midodrine | Phase 2 / Phase 3 | Recruiting | Ottawa Heart Institute Research Corporation | May 8, 2024 |
| MID-STEP (MIDodrine for Sepsis Treatment and Early vasoPressor Weaning) Trial | Midodrine | Phase 2 | Recruiting | Mayo Clinic | Mar 20, 2024 |
| Treatment of Orthostatic Hypotension in SCI | Midodrine | Phase 4 | Recruiting | James J. Peters Veterans Affairs Medical Center | May 3, 2023 |
| Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Refractory Ascites | Midodrine | — | Active, not recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | Jan 26, 2023 |
| Paediatric Syncope in the Emergency Department | Midodrine | Not applicable | Recruiting | Dr. Victoria Claydon | Sep 27, 2022 |
| Terazosin and Parkinson's Disease Extension Study | Terazosin | Phase 2 | Active, not recruiting | Cedars-Sinai Medical Center | Nov 5, 2021 |
| Midodrine for the Early Liberation of Vasopressor Support in the ICU (LIBERATE Multi-Site) | Midodrine | Phase 4 | Recruiting | University of Alberta | Sep 28, 2021 |
| Terazosin for Dementia With Lewy Bodies | Terazosin | Phase 1 / Phase 2 | Not yet recruiting | Qiang Zhang | Feb 18, 2021 |
| Alpha-1 Blockade for Alcohol Use Disorder (AUD) | Doxazosin, Prazosin | Phase 2 | Active, not recruiting | Brown University | Oct 23, 2019 |
| Predicting Responses to PTSD Treatment With Iris and Cardiovascular Tests | Prazosin | Phase 3 | Active, not recruiting | VA Office of Research and Development | May 29, 2018 |